Partner Content Partner Content Microbiome Drug Development Boston - Your Invite Pioneering The Microbiome Into Effective Medicines
Events Partner Content Microbiome Drug Development Boston 2018 Pioneering The Microbiome Into Effective Medicines
News PureTech licenses 'bacterial cocktail' to boost cancer immun... PureTech Health is to develop a combination of a microbiome treatment with checkpoint inhibitor immunotherapy to enhance the effect of the cancer drugs.
News Rebiotix microbiome drug success against C diff infection Patients suffering from a recurrent C diff infection have benefited from Rebiotix's microbiome treatment.
News UK spin-out Microbiotica wants to be world leader in microbi... Spin-out will exploit Sanger Institute expertise
News Novartis and J&J part of new US microbiome initiative The White House has launched a new national initiative focused on researching the microbiome with input from Novartis, Johnson & Johnson and others.
